Halyard Health (HYH) Raised to “B” at TheStreet
Halyard Health (NYSE:HYH) was upgraded by equities researchers at TheStreet from a “c+” rating to a “b” rating in a research note issued on Monday.
A number of other brokerages have also recently weighed in on HYH. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, November 4th. Stifel Nicolaus reissued a “buy” rating and issued a $52.00 price objective on shares of Halyard Health in a research report on Friday, November 3rd. Zacks Investment Research lowered Halyard Health from a “buy” rating to a “sell” rating in a research report on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Finally, BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $44.00.
Shares of Halyard Health (NYSE HYH) traded up $0.26 during trading on Monday, reaching $47.67. The company had a trading volume of 214,638 shares, compared to its average volume of 346,681. Halyard Health has a 52-week low of $35.24 and a 52-week high of $50.99. The firm has a market capitalization of $2,253.77, a PE ratio of 23.02, a P/E/G ratio of 2.60 and a beta of 1.77. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49.
Large investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC purchased a new position in Halyard Health in the first quarter valued at about $727,000. Koch Industries Inc. purchased a new position in Halyard Health in the second quarter valued at about $297,000. TIAA CREF Investment Management LLC raised its position in Halyard Health by 35.2% in the second quarter. TIAA CREF Investment Management LLC now owns 202,901 shares of the medical instruments supplier’s stock valued at $7,970,000 after purchasing an additional 52,881 shares during the period. Prudential Financial Inc. raised its position in Halyard Health by 3.9% in the third quarter. Prudential Financial Inc. now owns 686,309 shares of the medical instruments supplier’s stock valued at $30,904,000 after purchasing an additional 25,680 shares during the period. Finally, Schwab Charles Investment Management Inc. raised its position in Halyard Health by 3.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 797,993 shares of the medical instruments supplier’s stock valued at $31,346,000 after purchasing an additional 27,421 shares during the period. 90.31% of the stock is currently owned by institutional investors.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.